POST Online Media Lite Edition



 

Project managers do not always give accurate information to the boss

Staff writer |
The study reveals that teams across the land are not playing nicely after all. In fact, there are many occasions when we choose not to share information with colleagues if we think it can harm our own prospects of success.

Article continues below




And when that information determines, say, the level of funding passed down from a CEO, it can have a significant, and counter-productive, effect on the company as a whole.

"Most organisations must make decisions about where best to allocate resources," said Nektarios (Aris) Oraiopoulos of Cambridge Judge Business School, whose study, published in the journal Management Science, examined how these issues play out in the pharmaceutical industry.

"Pharmaceutical companies as a whole need to regularly reassess their research and development portfolios and decide which projects have the greatest potential; for example they might choose to improve an existing drug or develop a new one.

Such decisions are often made by executives who rely on information provided by the project managers. But individual project managers do not necessarily give accurate information to the boss if they think it will cost them the resources that fund their projects."

Oraiopoulos's study, undertaken with Vincent Mak of Cambridge Judge Business School, and Professor Jochen Schlapp of Mannheim University, revealed managers' likelihood to share information depended on whether there was an appropriate fit between the type of the project and the incentives scheme in place.

"In small companies such as start-ups, there's often such a strong culture of collective ambition and responsibility – and enhanced risk – that it's hard to attribute success or failure individually," said Oraiopoulos. "Therefore the most effective incentive rewards everyone on the basis of the collective success.

"But as the company grows, people inevitably assume singular responsibilities, the outcomes are less risky and, in the interests of the company, managers start following individual agendas – and management starts rewarding individual performance." Which is where the problems start.

"If two project managers are offered a group incentive for success, individuals are more willing to be upfront about any failings. But when the two project managers compete for resources and rewards, as it often happens in a bigger organisation, project managers are less likely to step aside."

There are many reasons for this, said Oraiopoulos, not necessarily based in deception. "Pharmaceutical research includes many 'true believers' – researchers who have absolute faith in a new product, especially if it could cure an important disease. But that faith skews their judgment. They believe their breakthrough is just around the corner, even if all the existing evidence suggests otherwise."

This is a difficult moral argument for any CEO to reject – a difficulty compounded by the lack of impartial information in such a knowledge-specific industry.

"One project manager's specialty might be cardiovascular, another's oncology," said Oraiopoulos. "No one knows the science and potential of their product better than they do. They can present an accurate case on why their project deserves resources – or, consciously or subconsciously, mask its failings because no-one has the expertise to challenge them. So how does the CEO tell the difference?"

The answer is trust and giving teams a compelling motivation to be honest. But a collective incentive has drawbacks. "If you're leading one of five departments who are rewarded only for collective excellence," said Oraiopoulos, "where's your motivation? You might as well let the others carry you."

And even financial incentive doesn't necessarily work. "Many researchers' greatest reward is completing their project," said Oraiopoulos. "That means being consistently confident their boss supports their work."

So what's the solution? "Organisations are tackling it in different ways," he said. "Some are creating smaller, individual units, for example, centres of excellence or turning departments into small start-ups, with defined budgets. Others are promoting more collaboration between departments."

Swiss global healthcare company Roche did both. When it bought drug developer Genentech in 2009 it kept the two companies' research and development sections separate, empowering its "late-stage development group" to pick the strongest project – and motivating the losing group by announcing it would develop its plans later. But while that worked with Alzheimer's treatments, a more linked approach was required for fast-paced developments in cancer research.

"The need to understand the biology and right therapeutic approach requires the best minds," said Roche's head of oncology Jason Coloma. "We needed to leverage the knowledge in these divisions and break down some of these firewalls."

The company formed a cancer immunotherapy committee which, says Roche, "brings the leadership and senior scientific minds together to consider different areas of interest and unmet needs that can be fulfilled by looking at different combinations."

Roche's approach confirms Oraiopoulos's findings that new products require a team strategy, while 'me-too' projects benefit from more individual approaches. But how to break down a colossal R&D function into start-up-style divisions?

GlaxoSmithKline replaced its research and development 'pyramid' with 12 centres of excellence. "We learned these centres must be built around two things," its then CEO Jean-Pierre Garnier said later.

"A specific mission – the most effective therapies for Alzheimer's – and the stage of the R&D process required to perform that mission, for example choosing a target for attacking the disease. Anything not critical to the core R&D process must occur outside the centre. All other functions – toxicology, drug metabolism, formulation, had to become service units, delivering at the lowest possible cost."

Simultaneously, GSK overhauled its incentives. "Pharmaceutical R&D typically pursues two objectives – to be first in class and to offer the best-in-class compound for attacking a disease. For too long the industry has tried to be a ballet dancer and a footballer at the same time."

But he warned fragmenting a company needs commitment. "To operate in this fashion, companies must strengthen opportunities, negotiate deals and nurture external scientific 'bets' (work with outside experts). This means a cultural shift. It's an enormous but necessary task."

Oraiopoulos's research suggests there are so many variables – different products, motivations, branches of medicine, organisational goals – each company must then find its own solution. Pfizer's recent buy-out of Botox maker Allergan is expected to maintain separate divisions for innovative and established treatments, so how the company allocates its resources remains to be seen.

"You must strike a balance," said Oraiopoulos, "between rewarding individual and group performance. It's a spectrum and each company must find their place on it, for patients and for the advancement of treatments. Many companies are encountering this challenge. We're only scratching the surface."


What to read next

You made a mistake. Should you tell your boss?
The first and the strongest
How to survive dangerous questions

500,000 UK employees strike

 
Half a million worker are on strike in what is the biggest day of industrial action in more than a decade today.
 
 

Latest

CP Q4 revenues $2.46 billion
TotalEnergies starts its fourth solar power plant in Japan
UK house prices continued to fall in January
Webb telescope catches early galaxy formation in action

NEWS

Fire put out at South Korea's space centre during test for next generation space rocket

Submarine volcano erupts in Vanuatu
UK faces fresh mass strikes
Reported death toll due to bad weather 44 in Philippines
After 1,400km long search missing radioactive capsule from Rio Tinto found in Australia
U.S.: Dangerous ice storm for portions of south
 

BUSINESS

Mayor Lightfoot celebrates completion of Terminal 5 at O’hare International Airport

Sustainable Energy Fund for Africa grant to drive electric mobility shift in 7 African countries
Battery-only electric passenger cars: +76% in Europe in 2021
UK drivers warned to keep eye on pump prices
Biden presents work on Baltimore tunnel, 72,000 new jobs expected
2022 Corruption Perceptions Index: Corruption levels remain at standstill
 

Trending Now

Sustainable Energy Fund for Africa grant to drive electric mobility shift in 7 African countries

Mayor Lightfoot celebrates completion of Terminal 5 at O’hare International Airport

South Africa authorises roll out of COVID-19 boosters to fight Omicron variant

After 1,400km long search missing radioactive capsule from Rio Tinto found in Australia


POLITICS

UK ready to boost CPTPP’s economic clout, says Trade Minister on Asia-Pacific visit

Commission approves €1.6 billion Romania measure to capitalise new investment and development bank
UK Government backing helps launch world first self-driving bus
Commission approves €104 million Croatian scheme to support energy-intensive companies
Canada invests in BHP project to develop world-leading low-emissions potash mine
New York: Over $22 million awarded in Round XII of Regional Economic Development Council Initiative
 

Today We Recommend

Biofertilizers market to surpass $5.71 billion


Highlights 

Novartis Q4 income declined 91 percent

GM and Lithium Americas to develop U.S. lithium production through $650 million deal

Biden presents work on Baltimore tunnel, 72,000 new jobs expected


COMPANIES

HVS awarded share of £6.6m government funding to develop world’s first self-driving hydrogen HGV

GM and Lithium Americas to develop U.S. lithium production through $650 million deal
Dole announces sale of its fresh vegetables division to Chiquita subsidiary Fresh Express
ExxonMobil awards FEED for world’s largest low-carbon hydrogen facility
Metronet begins construction of Daytona’s multi-gigabit 100 percent fiber optic network, will hire
Boeing to deliver last 747
 

CAREERS

Exothera appoints Darren Leva as chief business officer

Vesta taps Shimon Steinmetz as CFO
Bruno Ultra Barcelos appointed managing director of Ethypharm UK
Syntach names Patrick NJ Schnegelsberg as new CEO
Chiesi appoints Giuseppe Accogli as new group CEO
Foresters Financial Canada president Henry Auyeung to retire
 

ECONOMY

Italian economic growth stronger than expected in 2022

UK shop prices record high, peak still to come
GDP up by 0.1% in euro area and stable in EU
Portuguese economy sees fastest growth for 35 years in 2022
Canada's real GDP edged up 0.1% in November
Hungary: Economic sentiment ticks up in January
 

EARNINGS

Caterpillar Q4 profit decreases

Novartis Q4 income declined 91 percent
GSK Q4 profit climbs
Phillips 66 Q4 earnings $1.9 billion
McDonald's Q4 profit increases
Pfizer Q4 profit increases
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Ukraine opens Canadian, Serbian markets for export of livestock products since year beginning

Egypt intends to buy more wheat from Russia, working on system to pay in rubles
Rosselkhoznadzor stopped shipment of infected oats from Irkutsk to Mongolia
Philippines: ORION Program targets to perk up onion industry, increase domestic supply
Belarus lifts restrictions on food exports to neighboring EU countries
Argentina added new market: Algeria enabled export of meat with bone
 

LEADERSHIP

Lucky CEO means bad luck for hiring company

Product images could boost food pantry use
The madness of fast service: I want it now!
How to build a resilient brand
Only 32% of employees believe their pay is fair
Corporate duty waivers limit organic company growth and innovation
 

CRIME

AG for District of Colubia: $1,950,000 available for eligible Drizly drivers as result of tip-theft investigation

North Carolina: 52 stores pay fines for price scanning errors in 33 counties
EAO issued third fine for Coastal GasLink project
Dutch central bank fines cryptocurrency exchange Coinbase 3.3 mln euros
Bloomberg to pay $5 million for misleading disclosures about its valuation methodologies for fixed income securities
Italy fines Yoox with over 5 million euro for misleading prices and limitations of right of withdrawal
 

Magazine

TRAVEL

La Chandeleur in Paris: Crêpe Day for all of you

Tru by Hilton Monterrey Fundidora hotel opens in Mexico
IntercityHotel Berlin Airport BER opens
Art After School, the perfect way to spark imagination in your child
The world's biggest food fair in Berlin you don't wanna miss
Largest antiques show comes to small Texas town
 

SEA, LAND, AIR

Honda Pilot TrailSport, fully equipped SUV with great ground clearance

2024 Corvette E-ray, electrified 4WD
Jaguar I-PACE is now more distinctive
2023 Toyota Prius expected this January
2023 Lincoln Corsair, advance features and ActiveGlide
Lamborghini Huracán Sterrato, first super sports car for any terrain
 

DESIGN

Curved sofas, elegant and gentle

Solios watches, from nature to luxury
Coats of faux fur, but not of faux style
Redifining kitchen space and experience with workstations
Dinning sofas, a soft addition to a modern dinning table
Patchwork carpets, vintage Persian carpets made with unparalleled skill
 

GADGETS

Harman Luxury Audio introduces new JBL Classic Series

KEF KC62, audio excellence and design ingenuity
Panasonic announces flagship OLED TV MZ2000
McIntosh MC451, 150 Watt vacuum tube and 300 Watt solid state amplifier
Headonia 2A3, luxury headphone amplifier that comes with gloves
ASUS launches ExpertBook B9 for executives
 

HEALTH

South Africa authorises roll out of COVID-19 boosters to fight Omicron variant

FDA approves Orserdutm for patients with advanced or metastatic breast cancer
Indonesia to start rolling out COVID-19 vaccination for children under 6
Ipsen receives CHMP negative opinion for Palovarotene as treatment for fibrodysplasia ossificans progressiva in EU
Once-daily Sotyktu gets positive opinion as treatment for adults with moderate-to-severe plaque psoriasis
EMA update on shortages of antibiotics in EU
 

MEANTIME

Straigh and gay men both prefer masculine men for important jobs

Green comet to visit Earth after 50,000 years
Astronomers captured spectacular, ongoing collision between at least three galaxy clusters
NASA system predicts small asteroid to pass close by Earth this week
NASA, Pentagon developing nuclear-powered rocket for Mars
Milky Way found to be too big